Clinical Characteristics and Outcomes of Carbapenem-Resistant Gram-Negative Bacteria Pneumonia in Immunocompromised ICU Patients: A Retrospective Study
Infection and Drug Resistance · 2026-01 · Volume 19 · 1-14
DOI: 10.2147/idr.s569133 ↗Kurz gefasst
Fachartikel in der Zeitschrift Infection and Drug Resistance, 2026-01. Verfasst von Yiwei Gong und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Intensive Care Unit, Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, People's Republic of China. Die Arbeit nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Themen: Intensivpflege
Abstract (Originalsprache)
Background
Immunocompromised patients are increasingly admitted to intensive care units (ICUs), where carbapenem‑resistant Gram‑negative bacteria (CRGNB) pneumonia poses a growing threat due to limited treatment options and high mortality. This study aimed to compare the characteristics and outcomes of immunocompromised and immunocompetent ICU patients with CRGNB pneumonia and identify risk factors for ICU mortality.
Methods
We retrospectively analyzed the clinical characteristics, laboratory findings, and outcomes of patients with laboratory‑confirmed CRGNB pneumonia admitted to Third Affiliated Hospital of Sun Yat‑sen University from January 2021 to April 2025.
Results
Among 185 patients, 83 (44.9%) were immunocompromised, most often due to corticosteroid use (33.7%) or cancer chemotherapy (27.7%). Compared with immunocompetent patients, immunocompromised patients had higher rates of viral co-infection (36.1% vs 20.6%, p = 0.029), bacteremia (39.8% vs 15.7%, p 65 years (OR = 3.59, 95% CI: 1.20– 12.14, p = 0.02), and platelet count < 100 × 10 9 /L (OR = 3.26, 95% CI: 1.02– 12.12, p = 0.04). Among immunocompetent patients, vasopressor therapy (OR = 37.76, p < 0.001), CRRT (OR = 16.60, p = 0.001), pre-existing heart failure (OR = 3.26, p = 0.049), and IMV time/ICU LOS (OR = 1.48, p < 0.001) were independent mortality predictors, while tracheostomy was protective (OR = 0.13, p = 0.016).
Conclusion
Immunocompromised ICU patients with CRGNB pneumonia have distinct clinical characteristics, higher mortality, and risk factors that should be incorporated into prognostic evaluation and management. Keywords: intensive care unit, immunocompromised, carbapenem-resistant gram-negative bacteria, pneumonia, retrospective study
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medical Intensive Care Unit, Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, People's Republic of China.
ORCID-Profile: Jingcong Zhang, Yanhong Wang
Zitieren
APA
Gong, Y., Shi, Y., Ba, J., Lin, Y., Zhang, J., Hu, J., Luo, J., Wang, Y., & Wu, B. (2026). Clinical Characteristics and Outcomes of Carbapenem-Resistant Gram-Negative Bacteria Pneumonia in Immunocompromised ICU Patients: A Retrospective Study. Infection and Drug Resistance, Volume 19, 1-14. https://doi.org/10.2147/idr.s569133
Vancouver
Gong Y, Shi Y, Ba J, Lin Y, Zhang J, Hu J, et al. Clinical Characteristics and Outcomes of Carbapenem-Resistant Gram-Negative Bacteria Pneumonia in Immunocompromised ICU Patients: A Retrospective Study. Infection and Drug Resistance. 2026;Volume 19:1-14. doi:10.2147/idr.s569133
BibTeX
@article{Gong2026,
author = {Gong, Yiwei and Shi, Yunfeng and Ba, Junhui and Lin, Yusen and Zhang, Jingcong and Hu, Jiajia and Luo, Jinmei and Wang, Yanhong and Wu, Benquan},
title = {Clinical Characteristics and Outcomes of Carbapenem-Resistant Gram-Negative Bacteria Pneumonia in Immunocompromised ICU Patients: A Retrospective Study},
journal = {Infection and Drug Resistance},
year = {2026},
volume = {Volume 19},
pages = {1--14},
doi = {10.2147/idr.s569133}
}
EUVIMED